Submitted by Anonymous (not verified) on 30 August 2023 - 8:35
Opinion/decision on a Paediatric investigation plan (PIP): Deucravacitinib, decision type: , therapeutic area: , PIP number: P/0278/2022
Source:
Opinion/decision on a Paediatric investigation plan (PIP): Deucravacitinib, decision type: , therapeutic area: , PIP number: P/0278/2022